Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Complement depletion using recombinant human C3-derivatives

Complement depletion using recombinant human C3-derivatives

US Patent 7553931 · Granted Jun 30, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Induction of antigen-specific tolerance by peripheral phagocytosis2021
Controlled activation of complement components for use as endogenous adjuvant2019
Controlled activation of complement components for use as endogenous adjuvant2019
Complement depletion using recombinant human C-3 derivatives2012
Complement depletion using recombinant human C-3 derivatives2012
Complement depletion using recombinant human C-3 derivatives2012
Chimera of human IgE receptor α-chain and avian constant immuno-globulin domains2011
Bivalent IgY antibody constructs for diagnostic and therapeutic applications2010
Bivalent IgY antibody constructs for diagnostic and therapeutic applications2010
Recombinant proCVF2003
Recombinant procvf2001
In vivo binding pair pretargeting1999